1. Home
  2. OCC vs LITS Comparison

OCC vs LITS Comparison

Compare OCC & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optical Cable Corporation

OCC

Optical Cable Corporation

HOLD

Current Price

$7.94

Market Cap

48.8M

Sector

Industrials

ML Signal

HOLD

LITS

Lite Strategy Inc.

N/A

Current Price

$1.20

Market Cap

40.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCC
LITS
Founded
1983
2000
Country
United States
United States
Employees
N/A
4
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
40.8M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
OCC
LITS
Price
$7.94
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
136.0K
292.3K
Earning Date
03-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
290.91
N/A
EPS
N/A
N/A
Revenue
$87,828,590.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.03
N/A
52 Week Low
$2.40
$0.95
52 Week High
$11.50
$3.03

Technical Indicators

Market Signals
Indicator
OCC
LITS
Relative Strength Index (RSI) 61.73 52.44
Support Level $7.36 $1.17
Resistance Level $9.72 $1.27
Average True Range (ATR) 0.94 0.06
MACD 0.04 0.01
Stochastic Oscillator 69.01 61.11

Price Performance

Historical Comparison
OCC
LITS

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: